Thrivent Financial for Lutherans’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39.3M | Buy |
|
|||||
|
2025
Q1 | $42.2M | Sell |
|
|||||
|
2024
Q4 | $35.6M | Sell |
|
|||||
|
2024
Q3 | $42.6M | Sell |
|
|||||
|
2024
Q2 | $44.4M | Buy |
|
|||||
|
2024
Q1 | $37.2M | Buy |
|
|||||
|
2023
Q4 | $25M | Sell |
|
|||||
|
2023
Q3 | $26.3M | Sell |
|
|||||
|
2023
Q2 | $36.3M | Buy |
|
|||||
|
2023
Q1 | $23.1M | Sell |
|
|||||
|
2022
Q4 | $27.5M | Sell |
|
|||||
|
2022
Q3 | $27.6M | Sell |
|
|||||
|
2022
Q2 | $29.2M | Sell |
|
|||||
|
2022
Q1 | $27.4M | Buy |
|
|||||
|
2021
Q4 | $11.5M | Buy |
|
|||||
|
2021
Q3 | $8.04M | Sell |
|
|||||
|
2021
Q2 | $8.94M | Sell |
|
|||||
|
2021
Q1 | $9.54M | Sell |
|
|||||
|
2020
Q4 | $99.5M | Buy |
|
|||||
|
2020
Q3 | $108M | Sell |
|
|||||
|
2020
Q2 | $126M | Sell |
|
|||||
|
2020
Q1 | $116M | Sell |
|
|||||
|
2019
Q4 | $112M | Sell |
|
|||||
|
2019
Q3 | $88.8M | Buy |
|
|||||
|
2019
Q2 | $89.5M | Sell |
|
|||||
|
2019
Q1 | $107M | Sell |
|
|||||
|
2018
Q4 | $99.7M | Buy |
|
|||||
|
2018
Q3 | $66.3M | Sell |
|
|||||
|
2018
Q2 | $60.8M | Buy |
|
|||||
|
2018
Q1 | $15.7M | Sell |
|
|||||
|
2017
Q4 | $15.5M | Buy |
|
|||||
|
2017
Q3 | $14.9M | Buy |
|
|||||
|
2017
Q2 | $12.6M | Sell |
|
|||||
|
2017
Q1 | $11.8M | Sell |
|
|||||
|
2016
Q4 | $68.8M | Sell |
|
|||||
|
2016
Q3 | $101M | Buy |
|
|||||
|
2016
Q2 | $95M | Buy |
|
|||||
|
2016
Q1 | $80.1M | Sell |
|
|||||
|
2015
Q4 | $133M | Buy |
|
|||||
|
2015
Q3 | $107M | Buy |
|
|||||
|
2015
Q2 | $93.7M | Sell |
|
|||||
|
2015
Q1 | $108M | Sell |
|
|||||
|
2014
Q4 | $141M | Buy |
|
|||||
|
2014
Q3 | $123M | Buy |
|
|||||
|
2014
Q2 | $2.73M | Sell |
|
|||||
|
2014
Q1 | $5.18M | Buy |
|
|||||
|
2013
Q4 | $409K | Hold |
|
|||||
|
2013
Q3 | $417K | Sell |
|
|||||
|
2013
Q2 | $32.4K | Buy |
|